RecruitingNCT05714111
Radiology Registry on Pancreatic Malignancies
Sponsor
IRCCS San Raffaele
Enrollment
1,300 participants
Start Date
Mar 4, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to collect all radiological data which evaluated with clinical data may help assess malignancy and prognosis of pancreatic disease.This registry aims to collect retrospective data from 2014 and prospective data until 2027 with a maximum follow-up of 3 years per patient.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- ≥18 years of age
- Patients with suspect (planned for investigation) or diagnosed pancreatic cancer at any stage.
- able and willing to sign informed consent
Exclusion Criteria1
- Patients with non-primary pancreatic disease
Interventions
OTHERRadiology evaluations and interventions
Diagnostic and interventional radiology procedures
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05714111
Related Trials
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
NCT056635158 locations
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
NCT046786483 locations
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
NCT0697316127 locations
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
NCT0624477126 locations
Resilience and Equity in Aging, Cancer, and Health (REACH)
NCT046742671 location